$MRKY
MARKY CORP.

2023 Q3 Form 10-Q Financial Statement

#000197304723000016 Filed on September 11, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2 2023 Q1
Revenue $400.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $1.183K $0.00
YoY Change
% of Gross Profit
Operating Expenses $6.198K $5.164K
YoY Change
Operating Profit -$6.198K -$4.764K
YoY Change
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income
YoY Change
Income Tax
% Of Pretax Income
Net Earnings -$6.198K -$4.764K
YoY Change
Net Earnings / Revenue -1191.0%
Basic Earnings Per Share $0.00
Diluted Earnings Per Share
COMMON SHARES
Basic Shares Outstanding 3.500M shares 3.500M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2023 Q3 2023 Q2 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $646.00 $7.361K $646.00
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $646.00 $4.629K
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles $33.02K $8.700K
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $33.02K $8.700K
YoY Change
TOTAL ASSETS
Total Short-Term Assets $646.00 $4.629K
Total Long-Term Assets $33.02K $8.700K
Total Assets $33.66K $13.33K
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $15.00K $8.700K
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $41.49K $10.19K
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $41.49K $10.19K
Total Long-Term Liabilities
Total Liabilities $41.49K $10.19K
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings -$362.00
YoY Change
Common Stock $3.500K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$7.824K -$1.626K $3.138K
YoY Change
Total Liabilities & Shareholders Equity $33.66K $13.33K
YoY Change

Cashflow Statement

Concept 2023 Q3 2023 Q2 2023 Q1
OPERATING ACTIVITIES
Net Income -$6.198K -$4.764K
YoY Change
Depreciation, Depletion And Amortization $1.183K $0.00
YoY Change
Cash From Operating Activities -$1.264K
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$5.500K
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $9.496K
YoY Change
NET CHANGE
Cash From Operating Activities -$1.264K
Cash From Investing Activities -$5.500K
Cash From Financing Activities $9.496K
Net Change In Cash $2.732K
YoY Change
FREE CASH FLOW
Cash From Operating Activities -$1.264K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001973047
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--01-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q3 us-gaap Revenues
Revenues
usd
CY2022Q3 us-gaap Revenues
Revenues
usd
us-gaap Revenues
Revenues
usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
usd
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
usd
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
usd
CY2022Q3 us-gaap Fees And Commissions Mortgage Banking And Servicing
FeesAndCommissionsMortgageBankingAndServicing
usd
us-gaap Fees And Commissions Mortgage Banking And Servicing
FeesAndCommissionsMortgageBankingAndServicing
usd
CY2022Q3 us-gaap Depreciation
Depreciation
usd
us-gaap Depreciation
Depreciation
usd
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
usd
CY2022Q3 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
usd
CY2023Q3 us-gaap Interest Income Other
InterestIncomeOther
usd
CY2022Q3 us-gaap Interest Income Other
InterestIncomeOther
usd
us-gaap Interest Income Other
InterestIncomeOther
usd
us-gaap Interest Income Other
InterestIncomeOther
usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
usd
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
shares
CY2022Q2 us-gaap Shares Issued
SharesIssued
shares
CY2022Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
usd
CY2022Q3 us-gaap Shares Outstanding
SharesOutstanding
shares
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-07-31
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
333-271350
dei Entity Registrant Name
EntityRegistrantName
MARKY CORP.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
WY
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
32-0689703
dei Entity Address Address Line1
EntityAddressAddressLine1
San Sebastian 309, Martinica León
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
37500
dei Entity Address City Or Town
EntityAddressCityOrTown
Guanajuato
dei Entity Address Country
EntityAddressCountry
MX
dei City Area Code
CityAreaCode
186
dei Local Phone Number
LocalPhoneNumber
09730746
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
No
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
3500000 shares
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
646 usd
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
646 usd
CY2023Q3 us-gaap Deposits Savings Deposits
DepositsSavingsDeposits
646 usd
CY2023Q1 us-gaap Deposits Savings Deposits
DepositsSavingsDeposits
4629 usd
CY2023Q3 us-gaap Assets Current
AssetsCurrent
646 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
4629 usd
CY2023Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
33017 usd
CY2023Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
8700 usd
CY2023Q3 us-gaap Other Assets
OtherAssets
33017 usd
CY2023Q1 us-gaap Other Assets
OtherAssets
8700 usd
CY2023Q3 us-gaap Assets
Assets
33663 usd
CY2023Q1 us-gaap Assets
Assets
13329 usd
CY2023Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
15000 usd
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
8700 usd
CY2023Q3 us-gaap Loans And Leases Receivable Related Parties
LoansAndLeasesReceivableRelatedParties
26487 usd
CY2023Q1 us-gaap Loans And Leases Receivable Related Parties
LoansAndLeasesReceivableRelatedParties
1491 usd
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
41487 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
10191 usd
CY2023Q3 us-gaap Liabilities
Liabilities
41487 usd
CY2023Q1 us-gaap Liabilities
Liabilities
10191 usd
CY2023Q3 us-gaap Stockholders Equity Note Subscriptions Receivable
StockholdersEquityNoteSubscriptionsReceivable
3500 usd
CY2023Q1 us-gaap Stockholders Equity Note Subscriptions Receivable
StockholdersEquityNoteSubscriptionsReceivable
3500 usd
CY2023Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
11324 usd
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
362 usd
CY2023Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
7824 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-3138 usd
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
33663 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
13329 usd
us-gaap Revenues
Revenues
400 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
400 usd
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
10064 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
200 usd
CY2023Q3 us-gaap Fees And Commissions Mortgage Banking And Servicing
FeesAndCommissionsMortgageBankingAndServicing
15 usd
us-gaap Fees And Commissions Mortgage Banking And Servicing
FeesAndCommissionsMortgageBankingAndServicing
115 usd
CY2023Q3 us-gaap Depreciation
Depreciation
1183 usd
us-gaap Depreciation
Depreciation
1183 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
6198 usd
us-gaap Operating Expenses
OperatingExpenses
11362 usd
us-gaap Operating Expenses
OperatingExpenses
200 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
6198 usd
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
11362 usd
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
200 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-6198 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-10962 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-200 usd
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3500000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3500000 shares
CY2023Q2 us-gaap Shares Issued
SharesIssued
3500000 shares
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-1626 usd
CY2023Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-6198 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-200 usd
CY2023Q1 us-gaap Shares Issued
SharesIssued
3500000 shares
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
3138 usd
us-gaap Net Income Loss
NetIncomeLoss
-11362 usd
CY2023Q3 us-gaap Shares Outstanding
SharesOutstanding
3500000 shares
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-7824 usd
us-gaap Income Loss From Continuing Operations Attributable To Noncontrolling Entity
IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity
-200 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-200 usd
us-gaap Profit Loss
ProfitLoss
10962 usd
us-gaap Profit Loss
ProfitLoss
200 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
6300 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
17262 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
200 usd
us-gaap Increase Decrease In Due From Employee Current
IncreaseDecreaseInDueFromEmployeeCurrent
24996 usd
us-gaap Increase Decrease In Due From Employee Current
IncreaseDecreaseInDueFromEmployeeCurrent
200 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
24996 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
200 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
24996 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
200 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4629 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
646 usd
us-gaap Revenues And Gains Reporting Currency Denominated Value
RevenuesAndGainsReportingCurrencyDenominatedValue
400 usd
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_84F_eus-gaap--UseOfEstimates_z05He4w8d9qg" style="font: 12pt/12pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: justify; background-color: white"><b><i><span id="xdx_865_zbBOlqkarrL1">Use of Estimates</span></i></b></p> <p style="font: 12pt/12pt Times New Roman, Times, Serif; margin: 8pt 0 0; text-align: justify; text-indent: 24pt; background-color: white">The preparation of financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p>
CY2023Q3 us-gaap Cash
Cash
646 usd
CY2023Q1 us-gaap Cash
Cash
4629 usd
CY2023Q3 us-gaap Shares Issued
SharesIssued
3500000 shares
none Directorloan
Directorloan
24996 usd
none Directorloan
Directorloan
200 usd
none Website
Website
14200 usd
none Rssfeeds
Rssfeeds
20000 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
33017 usd

Files In Submission

Name View Source Status
0001973047-23-000016-index-headers.html Edgar Link pending
0001973047-23-000016-index.html Edgar Link pending
0001973047-23-000016.txt Edgar Link pending
0001973047-23-000016-xbrl.zip Edgar Link pending
ex31.htm Edgar Link pending
ex32.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
marky_10q.htm Edgar Link pending
MetaLinks.json Edgar Link pending
none-20230731.xsd Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
none-20230731_def.xml Edgar Link unprocessable
none-20230731_pre.xml Edgar Link unprocessable
marky_10q_htm.xml Edgar Link completed
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
none-20230731_cal.xml Edgar Link unprocessable
none-20230731_lab.xml Edgar Link unprocessable